Gina Lucas

AstraZeneca Pharmaceuticals LP
Director, Strategic Advice
Gina Lucas is a professional with over 25 years of GXP QA pharmaceutical industry experience. Her current role includes providing GCP strategic direction for Immuno-oncology programs at AstraZeneca including providing quality and compliance advice during study conduct, submission and health authority inspections. She has led and supported clinical site and sponsor inspection preparation and execution including FDA, EMA, PMDA and MoH regulatory authorities. Gina fosters a culture of inspection readiness and risk management, helping teams and functional areas prepare for and ensure inspection success. Her experience also includes due diligence activities, computerized systems QA, and GXP and patient assistance audit program management.